Investing can be fun and profitable at times, but it can also be a tricky thing. There are hundreds if not thousand of companies to choose from in dozens and dozens of industries. Some are new and thriving like wireless, broadband and social media. That’s great for companies like Qualcomm (QCOM), Entropic (ENTR) and Facebook (FB) and their shareholders. Others like newspapers such as the NY Times (NYT), book publishers and retail book stores like Barnes & Noble (BKS) are feeling the pain as their industry adapts to what I call the Always On, Always Connected society. The economy and industry fundamentals are not the only thing to watch and listen to with your investing eyes and ears. One other aspect is the regulatory environment and more specifically new regulations. As we know, business has been saddled with a number of them over the last few years, but none have the ability to impact a businesses’s cost structure like the Affordable Care Act. You know that far better as Obamacare. We’ve done a few PowerTalks already that have looked at the implications of Obamacare and other regulations. This week, we’re taking a different take and talking about how you can profit from these regulations. Joining me this week on PowerTalk are George Abraham and Sumesh Sood of Veda Healthcare Partners Veda is a hedge fund that has been in operation for more than two and a half years and invests in healthcare. From biotech and pharmaceuticals to managed care and generic drugs, these guys are looking at all of it with an eye toward delivering profits for their investors. Healthcare investing can be a tricky thing, but when we look around and see just the shifting demographics -- living longer, a heavier population, nutritional concerns and more -- it’s apparent that there are a number of pain points to be had. Pain points mean opportunity for the prepared investor. Let’s listen to what George and Sumesh see as remedies for not only these issues but also for your wallet.
